Search results
Researchers discover new target for potential leukemia therapy
Medical Xpress· 16 hours agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
White Hut Holyoke invites patrons to support baby’s recovery from acute myeloid leukemia
The Republican· 6 days agoAshton Conroy, the son of Holyoke Police Officer Crystal Conroy, is courageously battling acute ...
...for Treatment of Adenoid Cystic Carcinoma (ACC) and Acute Myeloid Leukemia/Myelodysplastic...
WFRV 5 Green Bay· 7 days agoAdditionally, the company also announced that REM-422 has received Orphan Drug Designation from the FDA for the treatment of ACC and AML...
CD7 expression tied to poorer outcomes with newly diagnosed leukemia
Medical Xpress· 5 days agoCD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid ...
New approach for developing cancer vaccines could make immunotherapies more effective in acute ...
Medical Xpress· 5 days agoIn a new study published in Blood Advances, researchers from the UChicago Pritzker School of...
Apollomics shares target cut on Phase 3 study results By Investing.com
Investing.com· 11 hours agoThe adjustment came in response to recently revealed Phase 3 study results which did not meet the...
2 Incredible Growth Stocks to Buy Hand Over Fist
Motley Fool via Yahoo Finance· 18 hours agoThis novel oral treatment for leukemia has the potential to surpass $1 billion in sales if it secures regulatory nods in both the front- and later-line...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 3 days agoThe study aimed to determine the efficacy of uproleselan in improving survival rates when used...
GlycoMimetics downgraded after Phase 3 trial fails to meet endpoint By Investing.com
Investing.com· 2 days agoGlycoMimetics' uproleselan, a drug candidate for treating relapsed or refractory acute myeloid ...
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 20 hours agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...